<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR12">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Shi</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Xie</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Rao</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Qian</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Mu</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Lv</surname>
    <given-names>P</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>TRAIL-expressing cell membrane nanovesicles as an anti-inflammatory platform for rheumatoid arthritis therapy</article-title>
  <source>J Control Release</source>
  <year>2020</year>
  <volume>320</volume>
  <fpage>304</fpage>
  <lpage>313</lpage>
  <pub-id pub-id-type="doi">10.1016/j.jconrel.2020.01.054</pub-id>
  <pub-id pub-id-type="pmid">32004586</pub-id>
 </element-citation>
</ref>
